+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists



Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists



Official Gazette of the United States Patent & Trademark Office Patents 1273(4), Aug 26



Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases.

(PDF emailed within 1 workday: $29.90)

Accession: 035980627

Download citation: RISBibTeXText



Related references

Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists. Official Gazette of the United States Patent & Trademark Office Patents 1239(3), Oct 17, 2000

Effects of n-3 PUFA on the CD4⁺ type 2 helper T-cell-mediated immune responses in Fat-1 mice. Molecular Nutrition & Food Research 58(2): 365-375, 2014

Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus. Journal of Immunology 159(1): 107-116, 1997

Cell-mediated and humoral immune responses in mice. IV. Difference of the functional cell population between helper activity and delayed-type hypersensitivity. Immunology 32(3): 237-245, 1977

Suppressor of cytokine signaling-3 enhances type 2 helper T cell mediated allergic immune responses. FASEB Journal 17(7): C144, April 14, 2003

Survival rate for different TNF-antagonists in the treatment of different immune mediated inflammatory diseases. 2006

Cell mediated and humoral immune responses in mice part 4 difference of the functional cell population between helper activity and delayed type hyper sensitivity. Immunology 32(3): 237-245, 1977

A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseases. Journal of Investigative Dermatology 112(5): 729-738, 1999

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. Journal of Experimental Medicine 190(7): 895-902, 1999

T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. Journal of Experimental Medicine 182(6): 1759-1767, 1995

Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases. Infectious Diseases (): 1-6, 2015

A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice. Immunology 126(1): 84-91, 2008

Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery (St Louis) 119(3): 316-325, 1996

Interleukin 12 as vaccine adjuvant, promotes T helper cell type 1 and suppresses Th cell type 2 immune responses. Cancer Biotherapy 10(1): 81, 1995